Literature DB >> 16406127

Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese.

G T C Ko1, C S Cockram, C C Chow, V T F Yeung, W B Chan, W Y So, N N Chan, J C N Chan.   

Abstract

In this report, we aimed to examine the impact of the new International Diabetes Federation (IDF) definition on the prevalence and clinical characteristics of subjects with metabolic syndrome (MES). Data were obtained from a prevalence survey for cardiovascular risk factors in a Hong Kong Chinese working population. There were 1513 subjects well representing all occupational groups from managers to general laborers [910 (60.1%) men and 603 (39.9%) women (mean age 37.5+/-9.2, median 37.0, range 18-66 years)]. The crude prevalence of MES defined by the IDF criterion was 7.4% (compared to other criteria: NCEP, 9.6%; WHO, 13.4% and EGIR, 8.9%). The age-standardized prevalence of MES by the IDF criterion was 8.8% in women and 7.3% in men. Subjects with MES defined by IDF criterion had higher body mass index and waist compared to those with MES defined by NCEP or WHO criteria, and lower triglyceride compared to those with MES defined by NCEP criterion after adjustment for age, gender and smoking. Non-MES subjects defined by IDF criterion had higher 2h glucose and insulin resistance compared to non-MES subjects defined by WHO. In conclusion, the new IDF criterion for MES is easy to implement in clinical practice. It may be potentially more 'specific' in identifying subjects with MES although compared to the NCEP criterion, it may have missed a proportion of subjects, especially men, who have metabolic derangement. Prospective and interventional studies are needed to validate the prognostic values of this new definition in comparison with other existing definitions.

Entities:  

Mesh:

Year:  2006        PMID: 16406127     DOI: 10.1016/j.diabres.2005.11.009

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

1.  Prevalence of metabolic syndrome in rural and urban Chinese population in Qingdao.

Authors:  J Zhao; Z C Pang; L Zhang; W G Gao; S J Wang; F Ning; H R Nan; J Ren; Q Qiao
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  The metabolic syndrome in China.

Authors:  Bernard M Y Cheung
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

3.  Association Between Elevated Liver Enzymes and Metabolic Syndrome Among Thai Adults.

Authors:  Sajithya Perera; Vitool Lohsoonthorn; Wiroj Jiamjarasrangsi; Somrat Lertmaharit; Michelle A Williams
Journal:  Diabetes Metab Syndr       Date:  2008-09

Review 4.  Perturbed autonomic nervous system function in metabolic syndrome.

Authors:  Nicholas Tentolouris; Georgia Argyrakopoulou; Nicholas Katsilambros
Journal:  Neuromolecular Med       Date:  2008-01-26       Impact factor: 3.843

5.  National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR Study.

Authors:  E Mannucci; M Monami; G Bardini; A Ognibene; C M Rotella
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

6.  Metabolic syndrome among obese Qataris attending primary health care centers in Doha, 2010.

Authors:  Mansoura F S Ismail
Journal:  J Family Community Med       Date:  2012-01

7.  Cardiovascular Risk Factors and Ethnicity Are Independent Factors Associated with Lower Urinary Tract Symptoms.

Authors:  Jasmine Lim; Nirmala Bhoo-Pathy; Selvalingam Sothilingam; Rohan Malek; Murali Sundram; Guan Hee Tan; Badrulhisham Bahadzor; Teng Aik Ong; Keng Lim Ng; Azad Hassan Abdul Razack
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study.

Authors:  Daniel Bressington; Jolene Mui; Mei Ling Tse; Richard Gray; Eric F C Cheung; Wai Tong Chien
Journal:  BMC Psychiatry       Date:  2016-11-18       Impact factor: 3.630

9.  Prevalence of the metabolic syndrome in a rural population in Ghana.

Authors:  Mawuli Gyakobo; Albert Gb Amoah; De-Anne Martey-Marbell; Rachel C Snow
Journal:  BMC Endocr Disord       Date:  2012-10-30       Impact factor: 2.763

10.  The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong--a cross sectional study.

Authors:  Daniel T Bressington; Jolene Mui; Eric F C Cheung; Joel Petch; Allan B Clark; Richard Gray
Journal:  BMC Psychiatry       Date:  2013-03-18       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.